Cargando…
p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program
BACKGROUND: Master transcription factor MyoD can initiate the entire myogenic gene expression program which differentiates proliferating myoblasts into multinucleated myotubes. We previously demonstrated that histone methyltransferase KMT1A associates with and inhibits MyoD in proliferating myoblast...
Autores principales: | Chatterjee, Biswanath, Wolff, David W., Jothi, Mathivanan, Mal, Munmun, Mal, Asoke K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993004/ https://www.ncbi.nlm.nih.gov/pubmed/27551368 http://dx.doi.org/10.1186/s13395-016-0100-z |
Ejemplares similares
-
Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells
por: Wolff, David W., et al.
Publicado: (2018) -
Too much AKT turns PAX3-FKHR dead: A prospect of novel therapeutic strategy for alveolar rhabdomyosarcoma
por: Jothi, Mathivanan, et al.
Publicado: (2012) -
Regulation of myogenic activation of p38 MAPK by TACE-mediated TNFα release
por: Li, Yi-Ping, et al.
Publicado: (2014) -
Dehydrocorydaline promotes myogenic differentiation via p38 MAPK activation
por: Yoo, Miran, et al.
Publicado: (2016) -
A Cdo–Bnip-2–Cdc42 signaling pathway regulates p38α/β MAPK activity and myogenic differentiation
por: Kang, Jong-Sun, et al.
Publicado: (2008)